why choose us

First received: November 20, 2022

Clinical Trial: A Study to Evaluate the Efficacy and Safety of AD-209

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hypertension, Essential

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Parallel, Multi-Center, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of AD-209 in Patients With Essential Hypertension

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of AD-209

Read more